What it's for (Indications)
- This combination medication, containing hydrocortisone and chloramphenicol, is indicated for the treatment of superficial bacterial infections of the eye or ear, where corticosteroid therapy is also required to reduce associated inflammation, swelling, and discomfort.
- Specifically, it is utilized in conditions such as bacterial conjunctivitis, bacterial blepharitis, and certain forms of bacterial keratitis (non-viral) affecting the eye, as well as bacterial otitis externa affecting the ear, especially when inflammatory symptoms like redness, itching, pain, and swelling are prominent.
- The chloramphenicol component provides broad-spectrum antibiotic action against susceptible bacterial pathogens, while hydrocortisone provides potent anti-inflammatory, anti-pruritic, and vasoconstrictive effects, thereby alleviating inflammatory signs and symptoms.
- This dual action aims to resolve both the infection and the accompanying inflammatory response effectively.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage and administration regimen for hydrocortisone and chloramphenicol combination products vary significantly based on the specific formulation (e.g., eye drops, eye ointment, ear drops), the concentration of active ingredients, and the severity and location of the infection and inflammation. Generally, for ophthalmic use, it typically involves applying 1 to 2 drops into the affected eye(s) or a small ribbon of ointment into the conjunctival sac 3 to 4 times daily. For otic use, 2 to 4 drops may be instilled into the affected ear canal 3 to 4 times daily. Treatment duration should be limited, often to no more than 7-10 days, to minimize the risk of corticosteroid-induced side effects (e.g., increased intraocular pressure) and the emergence of antibiotic resistance, unless explicitly directed by a healthcare professional following careful assessment. Adherence to the prescribed frequency and duration is crucial for optimal efficacy and safety, and treatment should not be abruptly discontinued. |
Safety & Warnings
Common Side Effects
- Patients using hydrocortisone and chloramphenicol topical preparations may experience a range of side effects, predominantly localized reactions at the site of application.
- Common adverse effects include transient stinging, burning, itching, or irritation.
- Ophthalmic use can lead to temporary blurred vision.
- More serious, although less common, effects associated with the corticosteroid component, especially with prolonged ophthalmic use, include increased intraocular pressure (which can potentially lead to glaucoma or optic nerve damage), and the formation of posterior subcapsular cataracts.
- There is also a risk of delayed wound healing.
- The chloramphenicol component, even with topical application, carries a rare but severe risk of systemic adverse effects, most notably bone marrow suppression, including fatal aplastic anemia, which is independent of dose.
- Hypersensitivity reactions such as rash, urticaria, and angioedema can also occur.
- Superinfection with non-susceptible organisms, including fungi, is a potential concern, particularly with prolonged use or improper administration.
Serious Warnings
- Black Box Warning: Despite the topical nature of this medication, significant systemic adverse effects, particularly associated with chloramphenicol, can occur. The most critical warning pertains to the potential for irreversible and fatal aplastic anemia, a severe form of bone marrow depression, which can develop independently of dose and may manifest weeks or months after treatment cessation. Other forms of bone marrow suppression, such as hypoplastic anemia, granulocytopenia, and thrombocytopenia, have also been reported. While primarily associated with systemic administration, systemic absorption can occur with topical use, especially with prolonged therapy, large surface areas, or compromised skin/mucosal barriers, necessitating vigilance. Additionally, prolonged topical ophthalmic use of corticosteroids like hydrocortisone carries a substantial risk of elevated intraocular pressure leading to glaucoma with damage to the optic nerve, visual acuity defects, and cataract formation. Regular monitoring of intraocular pressure is imperative for patients undergoing prolonged ophthalmic treatment. The benefits of this medication must be carefully weighed against these serious, potentially life-threatening risks.
- This combination product should be used with extreme caution and under strict medical supervision.
- Prolonged use of ophthalmic corticosteroids can lead to elevated intraocular pressure, potentially resulting in glaucoma with optic nerve damage, defects in visual acuity and fields, and posterior subcapsular cataract formation.
- It can also mask or exacerbate existing ocular infections (viral, fungal, or mycobacterial) or delay healing.
- Topical chloramphenicol carries a rare but serious risk of irreversible and fatal aplastic anemia, as well as other forms of bone marrow depression, which can occur after a short course of treatment.
- Patients should be monitored for signs of systemic absorption, especially if the treatment involves large surface areas, prolonged duration, or compromised skin/mucosa.
- Development of superinfection with non-susceptible bacteria or fungi warrants immediate discontinuation and initiation of appropriate therapy.
- Discontinue use if irritation, sensitization, or new infection develops.
- Not for use in viral or fungal eye/ear infections.
- Use in children should be carefully considered due to their potential for greater systemic absorption and increased risk of adverse effects.
How it Works (Mechanism of Action)
The therapeutic efficacy of this combination medication is derived from the distinct yet complementary pharmacological actions of its two active components. Hydrocortisone, a potent corticosteroid, exerts its anti-inflammatory, anti-pruritic, and vasoconstrictive effects primarily by inducing phospholipase A2 inhibitory proteins, known as lipocortins. These proteins control the biosynthesis of potent mediators of inflammation, such as prostaglandins and leukotrienes, by inhibiting the release of their common precursor, arachidonic acid. It also suppresses the migration of polymorphonuclear leukocytes and reverses capillary permeability, thereby reducing inflammatory responses. Chloramphenicol is a broad-spectrum antibiotic that acts by reversibly binding to the 50S ribosomal subunit of susceptible bacteria. This binding inhibits bacterial protein synthesis by preventing the formation of peptide bonds, ultimately leading to a bacteriostatic effect on rapidly multiplying organisms. Its spectrum includes many Gram-positive and Gram-negative bacteria, as well as some anaerobic organisms.
Commercial Brands (Alternatives)
No other brands found for this formula.